EP2266572
pyrimidylaminobenzamide derivative for use in the treatment of a TEL-PDGFRß-induced myeloproliferative disease
:
EP einkaleyfi: Þýðing ekki lögð inn:
2.5.2006:
21.9.2016:
10173672.6
:
1.5.2026
:
pyrimidylaminobenzamide derivative for use in the treatment of a TEL-PDGFRß-induced myeloproliferative disease
2.5.2006
21.9.2016
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
Manley, Paul W.:
Basel, CH
:
Mestan, Juergen:
Denzlingen, DE
:
Fabbro, Doriano:
Basel, CH
:
676751 P:
2.5.2005:
US
:
A61K 31/506, A61P 7/00, A61P 35/02